FP211
2292
Dr.Pooja Mayurbhai Khamar
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 2292 | Dr.Pooja Mayurbhai Khamar | dr.poojakhamar@gmail.com | 9742272111 |
Refractive Surgery
Ectasia After Refractive Surgery: Is LOX the Missing Biomarker?
Purpose: To determine if reduced Lysyl Oxidase (LOX) expression predicts ectasia despite normal preoperative topography and biomechanics. Methods: From a 12-year biorepository of 3,000+ lenticules, 6 ectasia cases were identified and analysed for LOX expression and genetic variants along with 12 controls. Prospectively, 210 lenticule extraction eyes underwent tear LOX assay; extracted lenticules were preserved and analysed. Low-LOX eyes received PRK (Photorefractive Keratectomy), or ICL (Implantable Collamer Lens). Results: All ectasia cases showed reduced LOX and COL1A1 despite normal topography and biomechanics. 65 low-LOX eyes received PRK, or ICL; CBI and SP-A1 correlated with LOX (p<0.05). At 5 years, treated eyes remained stable without ectatic progression. Conclusion: Reduced LOX and collagen, identifiable preoperatively, may predict ectasia risk despite normal screening. Tear LOX assay enables personalized risk stratification and targeted prophylactic intervention.
| Membership No | Author Name | Mobile | |
|---|---|---|---|
| 865 | Prof.Rohit Shetty | drrohitshetty@yahoo.com | 9611102568 |